The groundbreaking success of Viagra, developed by copyright, undeniably revolutionized the management of erectile impotence , and ignited a massive boom in the drug sector. However, now, investing in firms reliant on mature blockbuster drugs like Viagra presents a complex landscape. Generic competition is aggressive, significantly reducing profits